{
    "2020-12-18": [
        [
            {
                "time": "2021-03-15",
                "original_text": "U.S. FDA declines approval of Novartis cholesterol-lowering drug",
                "features": {
                    "keywords": [
                        "FDA",
                        "declines",
                        "approval",
                        "Novartis",
                        "cholesterol-lowering",
                        "drug"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2021-03-15",
                "original_text": "Novartis receives complete response letter from U.S. FDA for inclisiran",
                "features": {
                    "keywords": [
                        "Novartis",
                        "receives",
                        "complete",
                        "response",
                        "letter",
                        "FDA",
                        "inclisiran"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2021-03-15",
                "original_text": "Pharma Stock Roundup: FDA Emergency Nod to PFE/BNTX COVID-19 Vaccine, AZN to Buy ALXN",
                "features": {
                    "keywords": [
                        "Pharma",
                        "Stock",
                        "Roundup",
                        "FDA",
                        "Emergency",
                        "Nod",
                        "PFE",
                        "BNTX",
                        "COVID-19",
                        "Vaccine",
                        "AZN",
                        "Buy",
                        "ALXN"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}